BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16401694)

  • 1. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
    Kuhlmann MT; Kirchhof P; Klocke R; Hasib L; Stypmann J; Fabritz L; Stelljes M; Tian W; Zwiener M; Mueller M; Kienast J; Breithardt G; Nikol S
    J Exp Med; 2006 Jan; 203(1):87-97. PubMed ID: 16401694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization.
    Ohtsuka M; Takano H; Zou Y; Toko H; Akazawa H; Qin Y; Suzuki M; Hasegawa H; Nakaya H; Komuro I
    FASEB J; 2004 May; 18(7):851-3. PubMed ID: 15001565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
    Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
    Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis.
    Deindl E; Zaruba MM; Brunner S; Huber B; Mehl U; Assmann G; Hoefer IE; Mueller-Hoecker J; Franz WM
    FASEB J; 2006 May; 20(7):956-8. PubMed ID: 16571777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
    Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
    Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling.
    Lehrke S; Mazhari R; Durand DJ; Zheng M; Bedja D; Zimmet JM; Schuleri KH; Chi AS; Gabrielson KL; Hare JM
    Circ Res; 2006 Sep; 99(5):553-60. PubMed ID: 16873716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure.
    Milberg P; Klocke R; Frommeyer G; Quang TH; Dieks K; Stypmann J; Osada N; Kuhlmann M; Fehr M; Milting H; Nikol S; Waltenberger J; Breithardt G; Eckardt L
    Basic Res Cardiol; 2011 Nov; 106(6):995-1008. PubMed ID: 22072114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model.
    Lee SS; Naqvi TZ; Forrester J; Cattley R; Shah A; Frantzen M; Miyamoto T; Kaufman S; Price MJ; Lill M; Makkar RR
    Int J Cardiol; 2007 Mar; 116(2):225-30. PubMed ID: 16889856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse.
    Woldbaek PR; Hoen IB; Christensen G; Tønnessen T
    Acta Physiol Scand; 2002 Jul; 175(3):173-81. PubMed ID: 12100356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice.
    Osada T; Watanabe M; Hasuo A; Imai M; Suyama K; Sakai D; Kawada H; Matsumae M; Mochida J
    J Neurosurg Spine; 2010 Oct; 13(4):516-23. PubMed ID: 20887150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
    Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model.
    Fukuhara S; Tomita S; Nakatani T; Yutani C; Kitamura S
    J Heart Lung Transplant; 2005 Jan; 24(1):67-72. PubMed ID: 15653382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium.
    Cho SW; Gwak SJ; Kim IK; Cho MC; Hwang KK; Kwon JS; Choi CY; Yoo KJ; Kim BS
    Biochem Biophys Res Commun; 2006 Feb; 340(2):573-82. PubMed ID: 16376856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia.
    Zhao Q; Sun C; Xu X; Zhou J; Wu Y; Tian Y; Ma A; Liu Z
    J Cardiol; 2013 Jan; 61(1):87-94. PubMed ID: 23085036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction function through recruitment of beta-catenin and cadherin.
    Kuwabara M; Kakinuma Y; Katare RG; Ando M; Yamasaki F; Doi Y; Sato T
    FEBS Lett; 2007 Oct; 581(25):4821-30. PubMed ID: 17888912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.